Dateng Li

机构：Regeneron (United States) · ORCID：0000-0002-4287-5337

发表论文 27 篇 · 总被引 399 次 · h-index 10

代表论文

• Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events (2022 · Journal of Allergy and Clinical Immunology · 被引 97)
• ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression (2023 · Experimental & Molecular Medicine · 被引 89)
• Brief Alcohol Interventions are Effective through 6 Months: Findings from Marginalized Zero-inflated Poisson and Negative Binomial Models in a Two-step IPD Meta-analysis (2022 · Prevention Science · 被引 33)
• Decrotonylation of AKT1 promotes AKT1 phosphorylation and activation during myogenic differentiation (2022 · Journal of Advanced Research · 被引 30)
• <p>Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination</p> (2020 · Drug Design Development and Therapy · 被引 25)
• Targeting macrophage M1 polarization suppression through PCAF inhibition alleviates autoimmune arthritis via synergistic NF-κB and H3K9Ac blockade (2023 · Journal of Nanobiotechnology · 被引 23)